Whitepapers

Whitepaper Apr 13, 2026

Approval isn’t the Finish Line for Breakthrough Innovations in Neuroscience

Whitepaper Apr 2, 2026

The Medical Affairs Blueprint for Biotech

Whitepaper Mar 16, 2026

From Transactional to Transformational: Building Mutual Value in Expert Partnerships

Whitepaper Feb 19, 2026

Integrated Evidence Generation Planning: From Strategy to Execution

Whitepaper Jan 30, 2026

Oncology Outlook for 2026

Whitepaper Dec 2, 2025

Pressure on Pharmaceutical Prices

Whitepaper Nov 19, 2025

The European Medicines Agency’s Reflection Paper on Patient Experience Data

Whitepaper Nov 5, 2025

Elevating Cross-Functional Strategic Planning in Pharma

Whitepaper Nov 5, 2025

Real-World Evidence Without Borders: Navigating Evidence Transportability in HTA and JCA Decision-Making

Whitepaper Oct 30, 2025

What Counts in Cancer Care

Whitepaper Oct 23, 2025

Turning Cancer Insights into Autoimmune Disease Solutions

Whitepaper Sep 26, 2025

Defining the Future of Mental Health

Whitepaper Sep 23, 2025

A New Framework to Engineer Breakthrough Value for Medicines

Whitepaper Sep 9, 2025

Harnessing Real World Evidence for European Joint Clinical Assessments

Whitepaper Aug 17, 2025

Patient Centricity in Pharma: Rhetoric or Reality?

Whitepaper Aug 5, 2025

Integrated Evidence Generation Planning: A Strategic Imperative for Biopharma Innovation